Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Lipid peroxidation as cause of nigral cell death in Parkinson's disease.

Dexter D, Carter C, Agid F, Agid Y, Lees AJ, Jenner P, Marsden CD.

Lancet. 1986 Sep 13;2(8507):639-40. No abstract available.

PMID:
2875360
2.

Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease.

Dexter DT, Carter CJ, Wells FR, Javoy-Agid F, Agid Y, Lees A, Jenner P, Marsden CD.

J Neurochem. 1989 Feb;52(2):381-9.

PMID:
2911023
3.

Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study.

Dexter DT, Holley AE, Flitter WD, Slater TF, Wells FR, Daniel SE, Lees AJ, Jenner P, Marsden CD.

Mov Disord. 1994 Jan;9(1):92-7. Erratum in: Mov Disord 1994 May;9(3):380.

PMID:
8139611
4.
5.

Plasma levels of lipid peroxides in patients with Parkinson's disease.

Sanyal J, Bandyopadhyay SK, Banerjee TK, Mukherjee SC, Chakraborty DP, Ray BC, Rao VR.

Eur Rev Med Pharmacol Sci. 2009 Mar-Apr;13(2):129-32.

PMID:
19499848
6.

What process causes nigral cell death in Parkinson's disease?

Jenner P.

Neurol Clin. 1992 May;10(2):387-403. Review.

PMID:
1584181
7.

Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.

Jin L, Wang J, Zhao L, Jin H, Fei G, Zhang Y, Zeng M, Zhong C.

Brain. 2011 Jan;134(Pt 1):50-8. doi: 10.1093/brain/awq319. Epub 2010 Nov 24.

PMID:
21109502
8.

Oxidative mechanisms in nigral cell death in Parkinson's disease.

Jenner P.

Mov Disord. 1998;13 Suppl 1:24-34. Review.

PMID:
9613715
9.

Acetyl-L-carnitine and α-lipoic acid affect rotenone-induced damage in nigral dopaminergic neurons of rat brain, implication for Parkinson's disease therapy.

Zaitone SA, Abo-Elmatty DM, Shaalan AA.

Pharmacol Biochem Behav. 2012 Jan;100(3):347-60. doi: 10.1016/j.pbb.2011.09.002. Epub 2011 Sep 21.

PMID:
21958946
10.

Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.

Halliday GM, Ophof A, Broe M, Jensen PH, Kettle E, Fedorow H, Cartwright MI, Griffiths FM, Shepherd CE, Double KL.

Brain. 2005 Nov;128(Pt 11):2654-64. Epub 2005 Jul 6.

PMID:
16000336
12.

Selegiline (deprenyl) treatment and death of nigral neurons in Parkinson's disease.

Rinne JO, Röyttä M, Paljärvi L, Rummukainen J, Rinne UK.

Neurology. 1991 Jun;41(6):859-61.

PMID:
1904564
13.

Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease.

Boka G, Anglade P, Wallach D, Javoy-Agid F, Agid Y, Hirsch EC.

Neurosci Lett. 1994 May 19;172(1-2):151-4.

PMID:
8084523
14.

Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis.

Hirsch EC, Brandel JP, Galle P, Javoy-Agid F, Agid Y.

J Neurochem. 1991 Feb;56(2):446-51.

PMID:
1988548
15.

Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea.

Waters CM, Peck R, Rossor M, Reynolds GP, Hunt SP.

Neuroscience. 1988 May;25(2):419-38.

PMID:
2456487
16.

Complex I, iron, and ferritin in Parkinson's disease substantia nigra.

Mann VM, Cooper JM, Daniel SE, Srai K, Jenner P, Marsden CD, Schapira AH.

Ann Neurol. 1994 Dec;36(6):876-81.

PMID:
7998774
17.

Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease.

Dijkstra AA, Voorn P, Berendse HW, Groenewegen HJ; Netherlands Brain Bank, Rozemuller AJ, van de Berg WD.

Mov Disord. 2014 Sep;29(10):1244-51. doi: 10.1002/mds.25952. Epub 2014 Jul 3.

PMID:
24996051
18.

Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.

Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquez J, Mouatt-Prigent A, Ruberg M, Hirsch EC, Agid Y.

Histol Histopathol. 1997 Jan;12(1):25-31.

PMID:
9046040
19.

Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease.

Banati RB, Daniel SE, Blunt SB.

Mov Disord. 1998 Mar;13(2):221-7.

PMID:
9539333
20.

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.

Sian J, Dexter DT, Lees AJ, Daniel S, Agid Y, Javoy-Agid F, Jenner P, Marsden CD.

Ann Neurol. 1994 Sep;36(3):348-55.

PMID:
8080242

Supplemental Content

Support Center